CVE-2025-52203 json
A stored cross-site scripting (XSS) vulnerability exists in DevaslanPHP project-management v1.2.4.
published last yr. modified 4mo ago also EUVD-2025-23275
- cvss
- 7.6
- version 3.1, CNA
- cisa kev
- Not listed
- not in CISA's catalog
- epss
- 0.3%
- EPSS 0.3% chance of exploitation in 30 days, percentile 28%
- public exploits
- 0
- none known
Summary
A stored cross-site scripting (XSS) vulnerability exists in DevaslanPHP project-management v1.2.4. The vulnerability resides in the Ticket Name field, which fails to properly sanitize user-supplied input. An authenticated attacker can inject malicious JavaScript payloads into this field, which are subsequently stored in the database. When a legitimate user logs in and is redirected to the Dashboard panel "automatically upon authentication the malicious script executes in the user's browser context.
Is CVE-2025-52203 in your stack? Fencer shows which of your repositories are affected as soon as an advisory lands, and opens the fix as a pull request.
Check with FencerCISA SSVC
- Exploitation
- Proof of concept is public
- Automatable
- no
- Technical impact
- partial
- Assessed
- last yr.
Exploit prediction
0.35% chance of exploitation in the next 30 days, higher than 28% of all scored CVEs (FIRST EPSS, 2026-11-09).
Exploits and checks
- github.com https://github.com/ischyr/research-and-development/tree/main/CVE-2025-52203 referenced PoC, tagged "exploit" by a source, unverified
CVSS scores
| assigned by | version | score | vector |
|---|---|---|---|
| CISA ADP | 3.1 | 7.6 | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:H |
| CNA | 3.1 | 7.6 | CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:H |
Classification
- Weakness
-
- CWE-79 Improper Neutralization of Input During Web Page Generation
References
Sources
- CVE List CVE-2025-52203
- NVD CVE-2025-52203
Fencer Intel keeps one entry per vulnerability: the CVE id wins, then GHSA, and records that alias each other are merged, except that two CVEs always keep separate entries. The same data is available as JSON.